Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_assertion description "[Loss of CD52 expression in RS most likely predicts resistance to alemtuzumab therapy, which is frequently used in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_assertion evidence source_evidence_literature NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_assertion SIO_000772 25511139 NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_assertion wasDerivedFrom befree-2016 NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_assertion wasGeneratedBy ECO_0000203 NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1248307.RAGok0vvdcjgbm1DGnGaU5Vuz3LZf30Flb9KscCORwlDE130_provenance.